|
Bill Ericson joined MDV in 2000 after more than a decade of working closely with entrepreneurs to start and build innovative businesses in the role of lawyer, board member, entrepreneur and investor. Prior to MDV Mr. Ericson founded and ran Venture Law Group's Seattle office. Mr. Ericson was a member of the founding team of Rosetta Inpharmatics and served on its Board of Directors until its acquisition by Merck in 2001. Mr. Ericson serves on the Board of Northwestern University School of Law and is a member of the Personalized Medicine Coalition. He received his B.S.F.S. from Georgetown University of Foreign Service and J.D. from Northwestern University School of Law. | 